RAPT THERAPEUTICS INC (RAPT) Stock Analyst Ratings
NASDAQ:RAPT - US75382E1091 - Common Stock
11.39 USD
-0.48 (-4.04%)
ChartMill assigns a Buy % Consensus number of 77% to RAPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 24.65. This target is 116.42% above the current price.
RAPT was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about RAPT.
In the previous month the buy percentage consensus was at a similar level.
RAPT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-30 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2025-07-22 | LifeSci Capital | Initiate | Outperform |
| 2025-07-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-22 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-26 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-11-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-11-11 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-09-09 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-07-23 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-14 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-05-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-05-10 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-04-10 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-03-27 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-02-22 | UBS | Downgrade | Buy -> Neutral |
| 2024-02-21 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-21 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-21 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-02-21 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-02-20 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-02-16 | Evercore ISI Group | Initiate | Outperform |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |